JP7374000B2 - 肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物 - Google Patents

肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物 Download PDF

Info

Publication number
JP7374000B2
JP7374000B2 JP2019572783A JP2019572783A JP7374000B2 JP 7374000 B2 JP7374000 B2 JP 7374000B2 JP 2019572783 A JP2019572783 A JP 2019572783A JP 2019572783 A JP2019572783 A JP 2019572783A JP 7374000 B2 JP7374000 B2 JP 7374000B2
Authority
JP
Japan
Prior art keywords
liver
pharmaceutical composition
composition according
fat
hydroxybutyric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019572783A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020527547A (ja
JP2020527547A5 (enExample
Inventor
クラーク，キーラン
Original Assignee
ティーデルタス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ティーデルタス リミテッド filed Critical ティーデルタス リミテッド
Publication of JP2020527547A publication Critical patent/JP2020527547A/ja
Publication of JP2020527547A5 publication Critical patent/JP2020527547A5/ja
Priority to JP2023107837A priority Critical patent/JP7632979B2/ja
Application granted granted Critical
Publication of JP7374000B2 publication Critical patent/JP7374000B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
JP2019572783A 2017-06-27 2018-06-22 肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物 Active JP7374000B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023107837A JP7632979B2 (ja) 2017-06-27 2023-06-30 肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1710229.4A GB201710229D0 (en) 2017-06-27 2017-06-27 Compounds for new use
GB1710229.4 2017-06-27
PCT/GB2018/051752 WO2019002828A1 (en) 2017-06-27 2018-06-22 3-HYDROXYBUTYRATE COMPOUNDS FOR USE IN THE REDUCTION OF HEPATIC FAT

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023107837A Division JP7632979B2 (ja) 2017-06-27 2023-06-30 肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物

Publications (3)

Publication Number Publication Date
JP2020527547A JP2020527547A (ja) 2020-09-10
JP2020527547A5 JP2020527547A5 (enExample) 2021-07-29
JP7374000B2 true JP7374000B2 (ja) 2023-11-06

Family

ID=59523693

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019572783A Active JP7374000B2 (ja) 2017-06-27 2018-06-22 肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物
JP2023107837A Active JP7632979B2 (ja) 2017-06-27 2023-06-30 肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023107837A Active JP7632979B2 (ja) 2017-06-27 2023-06-30 肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物

Country Status (13)

Country Link
US (1) US12439944B2 (enExample)
EP (2) EP3644982B1 (enExample)
JP (2) JP7374000B2 (enExample)
KR (1) KR102680437B1 (enExample)
CN (1) CN110869012B (enExample)
AU (1) AU2018293398B2 (enExample)
CA (1) CA3066948A1 (enExample)
DK (1) DK3644982T3 (enExample)
ES (1) ES2945964T3 (enExample)
GB (2) GB201710229D0 (enExample)
PL (1) PL3644982T3 (enExample)
TW (1) TWI811222B (enExample)
WO (1) WO2019002828A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023120442A (ja) * 2017-06-27 2023-08-29 ティーデルタス リミテッド 肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201715654D0 (en) * 2017-09-27 2017-11-08 Tdeltas Ltd Method of treatment
GB2577723A (en) 2018-10-04 2020-04-08 Tdeltas Ltd Compounds for new use
JP7235873B2 (ja) * 2019-01-17 2023-03-08 アイオーアイ オレオ ゲーエムベーハー ヒドロキシカルボン酸のグリセリドの製造方法
CN109700021A (zh) * 2019-03-04 2019-05-03 清华大学 3-羟基丁酸及其衍生物在制备预防和治疗肥胖及肥胖相关疾病的产品中的应用
CN110776425B (zh) * 2019-10-23 2021-02-26 清华大学 一种(r)-3-羟基丁酸及其低聚物的制备方法
JP7638693B2 (ja) * 2020-12-15 2025-03-04 大阪瓦斯株式会社 ヒドロキシアルカン酸結晶の製造方法及びヒドロキシアルカン酸の結晶多形体
EP4256966A4 (en) * 2021-06-01 2024-12-11 Osaka Gas Co., Ltd. 3-hydroxybutyric-acid-containing oil and fat composition
US20240342121A1 (en) * 2021-07-09 2024-10-17 Georgia State University Research Foundation, Inc. The use of beta-hydroxybutyrates for the treatment or prevention of aneurysms and dissections
IT202100020441A1 (it) * 2021-07-30 2023-01-30 Unichem Estense S R L Miscela di un mono-estere e un di-estere, in cui detti mono-estere e di-estere sono esteri dell’acido (R)-3-idrossibutanoico con un polialcol, processo per la preparazione della miscela e relativi usi medici
CN113712140A (zh) * 2021-09-13 2021-11-30 珠海麦得发生物科技股份有限公司 一种含(r)-3羟基丁酸的固体饮料及其制备方法
CA3236459A1 (en) * 2021-11-04 2024-05-11 Gleb ANDRYIANAU Ketone precursors and methods therefor
IL312317B2 (en) * 2021-11-12 2025-04-01 Arxada Ag Polyol-derived compounds
AU2022417093A1 (en) * 2021-12-14 2024-06-13 Suntory Holdings Limited Beverage containing 3-hydroxybutyric acid and lower aliphatic alcohol, and method for improving taste
WO2023112818A1 (ja) * 2021-12-14 2023-06-22 サントリーホールディングス株式会社 炭酸飲料及び炭酸飲料の炭酸感を増強する方法
JP7223193B1 (ja) 2022-05-26 2023-02-15 大阪瓦斯株式会社 内臓脂肪低減剤およびその用途
CN116966173A (zh) * 2023-06-15 2023-10-31 浙江大学 3-羟基苯乙酸在制备改善非酒精性脂肪肝药物中的应用
CN118903420A (zh) * 2024-07-02 2024-11-08 南方医科大学 Irf4抑制剂在治疗非酒精性脂肪性肝炎的应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001515510A (ja) 1997-03-17 2001-09-18 ビーティージー・インターナショナル・リミテッド 治療用組成物
JP2001527101A (ja) 1997-12-22 2001-12-25 メタボリックス，インコーポレイテッド 制御された分解速度を有するポリヒドロキシアルカノエート組成物
JP2004507572A (ja) 2000-07-14 2004-03-11 メタボリックス，インコーポレイテッド ヒドロキシアルカノエート及びイソシアネ―トから得られるポリウレタン
WO2011078204A1 (ja) 2009-12-24 2011-06-30 浜理薬品工業株式会社 高脂血症の予防または治療剤、および抗疲労剤
JP2012500264A (ja) 2008-08-21 2012-01-05 アイシス イノヴェイション リミテッド ヒドロキシ酪酸エステル及びその医学的使用
WO2016123229A1 (en) 2015-01-29 2016-08-04 Yale University Compositions and methods for treating nlrp3 inflammasome-related diseases and disorders

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248321B (it) * 1991-05-15 1995-01-05 Sigma Tau Ind Farmaceuti Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US20090253781A1 (en) 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US20060280721A1 (en) * 2003-06-03 2006-12-14 The Gov Of Usa Represented By Secretary Of Dpt Of Nutritional supplements and therapeutic compositions comprising (r)-3- hydroxybutyrate derivatives
SE0400355D0 (sv) * 2004-02-17 2004-02-17 Synbiotics Ab New synbiotec use
US7947736B2 (en) 2004-07-16 2011-05-24 Btg International Limited Oligomeric compounds
US7485743B2 (en) 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds
WO2008110034A1 (en) * 2007-03-14 2008-09-18 Shantou University 3-hydroxy fatty acid and its derivatives for improving of learning and/or memory of subjects
CN106038532B (zh) 2008-01-04 2019-05-14 牛津大学科技创新有限公司 用作降低血脂药剂的酮体和酮体酯
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
US8865641B2 (en) * 2011-06-16 2014-10-21 The Feinstein Institute For Medical Research Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways
GB201206192D0 (en) * 2012-04-05 2012-05-23 Tdeltas Ltd Ketone bodies and ketone body esters and for maintaining or improving muscle power output
EP2984066B1 (en) 2013-03-14 2017-02-01 Oxford University Innovation Limited Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate
PE20151949A1 (es) 2013-03-19 2016-01-05 Univ South Florida Composiciones y metodos para producir cetosis elevada y sostenida
EA201592020A1 (ru) * 2013-04-22 2016-05-31 Кадила Хелзкэр Лимитед Новая композиция для неалкогольной жировой болезни печени (нажбп)
US11814664B2 (en) * 2013-05-24 2023-11-14 Genomatica, Inc. Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate
GB201314127D0 (en) 2013-08-07 2013-09-18 Tdeltas Ltd Ketone body and ketone body ester for reducing muscle breakdown
US20150283163A1 (en) 2014-04-04 2015-10-08 Organic Medical Ventures, L.L.C. Muscle treatment composition and method making same
CA2979033A1 (en) * 2015-03-09 2016-09-15 Intekrin Therapeutics, Inc. Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
CA3021784A1 (en) * 2016-04-19 2017-10-26 Keto Patent Group, Inc. Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
US10336812B2 (en) * 2016-05-10 2019-07-02 Janssen Biotech, Inc. GDF15 fusion proteins and uses thereof
GB201710229D0 (en) 2017-06-27 2017-08-09 Tdeltas Ltd Compounds for new use

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001515510A (ja) 1997-03-17 2001-09-18 ビーティージー・インターナショナル・リミテッド 治療用組成物
JP2001527101A (ja) 1997-12-22 2001-12-25 メタボリックス，インコーポレイテッド 制御された分解速度を有するポリヒドロキシアルカノエート組成物
JP2004507572A (ja) 2000-07-14 2004-03-11 メタボリックス，インコーポレイテッド ヒドロキシアルカノエート及びイソシアネ―トから得られるポリウレタン
JP2012500264A (ja) 2008-08-21 2012-01-05 アイシス イノヴェイション リミテッド ヒドロキシ酪酸エステル及びその医学的使用
WO2011078204A1 (ja) 2009-12-24 2011-06-30 浜理薬品工業株式会社 高脂血症の予防または治療剤、および抗疲労剤
WO2016123229A1 (en) 2015-01-29 2016-08-04 Yale University Compositions and methods for treating nlrp3 inflammasome-related diseases and disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JACOBS, R. L. et al，Creatine Supplementation may prevent NAFLD by stimulating fatty acid oxidation，The FASEB Journal，2013年，Vol.27, Issue S1，p.222.2

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023120442A (ja) * 2017-06-27 2023-08-29 ティーデルタス リミテッド 肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物
JP7632979B2 (ja) 2017-06-27 2025-02-19 ティーデルタス リミテッド 肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物

Also Published As

Publication number Publication date
KR102680437B1 (ko) 2024-07-01
CA3066948A1 (en) 2019-01-03
GB2567273B (en) 2020-10-07
JP2020527547A (ja) 2020-09-10
GB201810300D0 (en) 2018-08-08
TWI811222B (zh) 2023-08-11
CN110869012A (zh) 2020-03-06
GB2567273A (en) 2019-04-10
JP7632979B2 (ja) 2025-02-19
EP3644982B1 (en) 2023-04-12
EP3644982A1 (en) 2020-05-06
US20200113220A1 (en) 2020-04-16
WO2019002828A1 (en) 2019-01-03
GB201710229D0 (en) 2017-08-09
AU2018293398A1 (en) 2020-01-16
EP4215189A1 (en) 2023-07-26
ES2945964T3 (es) 2023-07-11
DK3644982T3 (da) 2023-07-17
CN110869012B (zh) 2024-06-11
JP2023120442A (ja) 2023-08-29
KR20200019745A (ko) 2020-02-24
PL3644982T3 (pl) 2023-08-14
AU2018293398B2 (en) 2023-11-23
TW201904568A (zh) 2019-02-01
US12439944B2 (en) 2025-10-14

Similar Documents

Publication Publication Date Title
JP7632979B2 (ja) 肝臓脂肪を減らすことにおいて使用するための３－ヒドロキシ酪酸化合物
JP7427572B2 (ja) 栄養組成物
US12370165B2 (en) Hunger suppression
US12226387B2 (en) Compounds for use in cancer cachexia

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210618

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210618

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220628

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220920

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221125

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230630

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230713

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230926

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231017

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231024

R150 Certificate of patent or registration of utility model

Ref document number: 7374000

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150